5、据招股说明书：公司智能操控系统属于"软硬件一体化"产品。硬件部分主要包括各类具备传感、传 输、控制、算力等功能的硬件或软件载体，硬件部分除了变频器以外，公司主要通过外采取得；软件部 分主要包括各类感知、决策、执行及交互类算法或软件，软件部分主要由公司自主研发，系公司根据不 同行业设备的作业需求，结合硬件产品特性，自行搭建软件系统构架，并自主开发各构架层算法或软 件。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 来源：新浪证券-红岸工作室 12月8日，港迪技术涨0.38%，成交额1801.28万元，换手率1.04%，总市值37.84亿元。 异动分析 新型工业化+机器人概念+专精特新+高端装备+信创 1、武汉港迪技术股份有限公司主营业务是工业自动化领域产品研发、生产与销售。主要产品是自动化 驱动产品、智能操控系统。 2、2025年10月28日互动易：公司自主研发的 SD400 系列伺服系统，凭借超快速响应、高精度位置控 制、高稳定性以及紧凑的设计等特性，已实现对机器人应用（关节驱动、喷涂路径优化、焊接工艺精准 执行）的适配，可有效帮助下游客户提升设备生产良率与作业效率，相 ...

Core Viewpoint - The company, Nantong Planet Graphite Co., Ltd., is actively expanding its international market presence, particularly in India and Southeast Asia, through significant contracts and projects in the chemical equipment sector. Group 1: Company Developments - On December 20, 2023, the company signed a product sales contract with Adani Group's subsidiary for a total amount of approximately 29,990.73 million RMB, involving 100,000 tons of green PVC project-related graphite equipment [2] - The company has successfully ignited a three-in-one hydrochloric acid synthesis furnace for its recent projects in Vietnam, indicating progress in its operational capabilities [2] - The company is recognized as one of the first batch of "specialized, refined, distinctive, and innovative" small giant enterprises, highlighting its strong innovation capabilities and market position [3] Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 498 million RMB, reflecting a year-on-year growth of 10.69%, while the net profit attributable to shareholders decreased by 17.76% to 80.8015 million RMB [7] - The company has distributed a total of 205 million RMB in dividends since its A-share listing, with 140 million RMB distributed over the past three years [8] Group 3: Market Position and Shareholder Information - As of September 30, 2025, the company had 4,207 shareholders, an increase of 19.38% from the previous period, with an average of 34,173 circulating shares per person, a decrease of 16.23% [7] - The company's main business revenue composition includes 53.78% from graphite equipment, 20.66% from equipment parts, and 10.99% from maintenance services [7]

来源：星岛产研 12月4日，杭州朱炳仁铜艺股份有限公司（NQ：874779）宣布完成上市辅导备案，拟冲刺北交所IPO， 辅导机构为浙商证券。 朱炳仁铜以"百年铜艺世家"之名冲击北交所IPO，在一众以"专精特新"为特色的科技企业中显得与众不 同，其获取的百余项专利大部分是外观设计专利而非发明专利。此外，近年来公司财务方面增收不增 利、依赖朱炳仁个人IP、高度家族化管理的情况，也是其IPO路上不可忽视的挑战。 "迈巴赫少爷"背后的百年铜雕世家 朱炳仁·铜的故事始于1875年清末同治年间在绍兴创立的"朱府义大铜铺"，至今已传承五代。 朱家铜铺的第四代传承人朱炳仁是中国铜雕领域泰斗级人物，国家级工艺美术大师、国家级非遗铜雕技 艺传承人、北京故宫博物院文创顾问、中国艺术研究院研究员。 朱炳仁之子朱军岷则继承了非遗传承衣钵，并开创"朱炳仁·铜"品牌推动产业化。2011年8月，朱炳仁铜 公司成立，实际控制人朱军岷兄妹目前持股近八成。朱军岷本人也是国家级非遗铜雕技艺传承人、浙江 省工艺美术大师。 | 项目 | 2024 年度 | 2023 年度 | | --- | --- | --- | | 营业收入(万元) | 61.98 ...

业内人士表示，随着北交所上市公司数量和规模不断增长，北证50成份指数的投资价值或更为突出，相 关基金产品也会进一步丰富。 北证50指数基金表现亮眼 来源：中国基金报 近日，首批北证50成份指数型基金迎来面市三周年。数据显示，首批8只产品成立以来收益均为正，最 高达66.65%。 北京一家大型基金公司表示，当前，北交所上市公司数量持续增加，质量也在提升，而且政策红利不断 释放，比如优化兼并重组、支持专精特新企业上市等，市场对北证50指数的关注度会越来越高。同时， 中长期资金入市需求也在上升，后续会有更多机构布局相关产品。 估值仍有支撑 至于北证50指数当前估值，邓童指出，指数的估值水平较前两年有了较大幅度的抬升，这主要是由于北 交所流动性显著改善，尤其是近两年机构资金进入，个股流动性折价基本消失，估值水平也来到了较高 位置。 北京一家大型基金公司表示，虽然北证50指数估值比主板高，但其估值有成长性作为支撑。 投资价值方面，邓童表示，北交所扩容速度很快，上市公司数量及市值增长均超过3倍，交易量增长更 加显著。同时，北交所上市公司的质量不断提升，以专精特新为特色，聚集了一大批细分行业龙头。北 证50指数作为北交所最 ...

本报北京12月7日电 （记者王洲）截至11月30日，北京专精特新专板企业达1000家，提前完成专板培育 企业数量目标，专板企业高精尖产业集聚特征显著。其中，近九成归属新一代信息技术、软件和信息服 务、人工智能、生物医药、智能制造、新能源等前沿领域。此外，高研发也是专板企业呈现出的一大突 出特点，近七成企业在研发上的投入超过行业平均水平。 北京股权交易中心将专板建设与专精特新中小企业上市培育融合，通过上市政策宣讲、专板服务讲解、 上市路径选择、三四板协同发展等一系列主题培训活动，不断发挥专板作为专精特新企业挂牌上市"蓄 水池"的功能。专板面向北京市专精特新等优质中小企业提供股债融资、上市培育等综合金融服务，深 化多层次资本市场互联互通。 《 人民日报 》（ 2025年12月08日 06 版） (责编：赵欣悦、袁勃) 关注公众号：人民网财经 ...

Core Viewpoint - The continuous deepening of the New Third Board reform presents development opportunities for securities companies serving innovative small and medium-sized enterprises (SMEs) in China [2] Group 1: Company Strategy and Services - The company has been engaged in the New Third Board market for nearly 15 years, focusing on supporting the innovative development of SMEs [3] - The establishment of a "Growth Enterprise Financing Department" and a "Mergers and Acquisitions Financing Department" reflects the company's shift towards integrated financial services, moving beyond traditional IPO sponsorship [2][3] - The company provides a "one-stop" service for SMEs, integrating resources from banking, trust, insurance, asset management, and industrial funds to facilitate entrepreneurship and financing [3] Group 2: Market Position and Achievements - The company has recommended over 150 enterprises to list on the Hunan Equity Exchange, with 31 listings completed in 2024, 28 of which are specialized and innovative enterprises [3] - The selection criteria for enterprises include "three advantages and one specialization," focusing on stable profitability, rapid growth, significant potential, and specialization in key industries [3] Group 3: Challenges and Solutions - The company identifies three main challenges in connecting with innovative SMEs: stricter review standards, performance volatility, and talent and capital bottlenecks [4][5] - To address these challenges, the company offers full-cycle services, including regulatory compliance support, mergers and acquisitions alternatives, and various financing options [5] Group 4: Future Plans and Strategic Focus - The company aims to leverage its group synergy to provide comprehensive financial services for technology innovation enterprises across Hunan and nationwide [6] - The future strategic plan includes a focus on the North Exchange business, expanding mergers and acquisitions, and enhancing research capabilities [7] - The company emphasizes the importance of industry research, collaborative capabilities, and risk management as core competencies to support its strategic goals [7]

Group 1: North Exchange Market Overview - In 2025, the North Exchange market achieved significant breakthroughs, with total market value exceeding 820 billion, number of accounts reaching 9.5 million, and average daily trading volume approaching 30 billion, indicating a qualitative leap in liquidity [6][8]. - The market's focus on "specialized, refined, distinctive, and innovative" characteristics is evident, with national-level "little giant" companies accounting for 61%, fostering a matrix of high-growth and scarce enterprises in sectors like new energy, robotics, and AI [6][8]. - The average net profit of newly listed companies in 2024 increased from 30 million to 110 million, reflecting continuous improvement in enterprise quality [6]. Group 2: Investment Strategy for 2026 - The North Exchange will deepen its layout around "scarcity" and "new productive forces" as it enters the 15th Five-Year Plan, with policies expected to continue promoting innovation in fund products and optimizing the IPO mechanism [8][9]. - The average first-day IPO gain in the first 11 months of 2025 was 356%, with average subscription funds exceeding 640 billion, indicating a vibrant IPO market expected to continue into 2026 [8]. - Public fund holdings reached 22.4 billion in the first half of 2025, with a clear trend of dual-driven growth from active and passive funds, and the introduction of new ETF products is anticipated to inject significant capital [8][9]. Group 3: Metal New Materials Sector - Copper prices have risen significantly, with weekly increases of 5.74% in London copper and 6.12% in Shanghai copper, driven by macroeconomic factors and a substantial reduction in domestic copper inventories [12][13]. - The supply-demand balance for copper is shifting from tight equilibrium to potential shortages due to insufficient capital expenditure in copper mining and frequent supply disruptions [12]. - Aluminum prices are also on the rise, with a 3.28% increase in Shanghai aluminum, supported by stable demand and limited supply growth [13]. Group 4: Pharmaceutical Sector Insights - The pharmaceutical index fell by 0.74%, but the sector is expected to see a wave of valuation recovery in the first half of 2026 due to numerous innovation drug catalysts [18][21]. - ZG006 from Zai Lab shows promising clinical data for treating refractory small cell lung cancer, with response rates of 60% and 66.7% in different dosage groups, indicating a significant market potential [20][21]. - Recommended stocks in the pharmaceutical sector include Xinyi Tai, Zai Lab, and Heng Rui Medicine, focusing on companies with clear performance trends and potential for operational reversals in 2026 [23].

Group 1 - The article emphasizes the importance of efficiently navigating through a large volume of announcements each night, highlighting the role of "Announcement Selection" in providing key insights and investment opportunities [1] - The company has successfully delivered complex functional components made of metamaterials, which are now being applied in various new-generation aerospace equipment in China [1] - The company has achieved mass production and sales of new energy carbon materials, including supercapacitor carbon and porous carbon, which are relevant for air treatment and energy storage [1] - The company plans to acquire a robotics technology development firm specializing in embodied intelligent robots, aligning with trends in smart cities and artificial intelligence [1]

Core Insights - The first batch of North Exchange 50 index funds has shown impressive performance, with all eight funds achieving positive returns since their inception, the highest being 66.65% [1][3]. Performance Summary - As of December 5, the average net asset value growth rate of the first eight North Exchange 50 index funds is 41.15%, with the highest at 66.65% [3]. - The strong performance is attributed to the recovery of liquidity discounts in North Exchange stocks and a significant market rebound over the past year [3]. Market Expansion - By the end of Q3 this year, the number of North Exchange 50 index funds has expanded to nearly 30, with a total scale exceeding 12.5 billion, representing a growth of 171.73% since the end of 2022 [4]. - Due to high demand, seven of the first eight funds are currently in a "suspension of large-scale subscriptions" status to maintain stable operations and avoid short-term speculative impacts [4]. Valuation and Growth Potential - The valuation of the North Exchange 50 index has significantly increased due to improved liquidity and the entry of institutional funds, with the current valuation being higher than that of the main board [6][7]. - The North Exchange is rapidly expanding, with the number of listed companies and their market capitalization growing over threefold, and trading volume showing significant increases [7]. Investment Value - The North Exchange 50 index is increasingly representative, consisting of the 50 largest and most liquid stocks from the North Exchange, making it a key indicator of core opportunities [8]. - The index aligns well with national policy support for emerging industries such as electric equipment, computing, and biomedicine, which are expected to drive future performance [8]. - Improved liquidity and fundamental performance are noted, with daily trading volume since 2025 being nearly four times that of the initial two years, indicating smoother capital flows [8].

Core Viewpoint - The first batch of North Exchange 50 index funds has performed well in their three years since launch, with all eight products showing positive returns, the highest being 66.65% [2][4]. Performance of North Exchange 50 Index Funds - As of December 5, the eight North Exchange 50 index funds launched in December 2022 have an average net value growth rate of 41.15%, with the highest at 66.65% [4]. - The funds benefited from the recovery of liquidity discounts in North Exchange stocks and the overall market rebound over the past year [4]. - The North Exchange 50 index funds provide a channel for ordinary investors to participate in North Exchange stocks, which have certain investment thresholds [4]. Market Expansion and Fund Size - By the end of Q3 this year, the number of North Exchange 50 index funds has expanded to nearly 30, with a total scale exceeding 12.5 billion, a growth of 171.73% compared to the end of 2022 [5]. - Seven of the initial eight funds are currently in a "suspension of large subscriptions" status due to liquidity constraints in individual stocks [6]. Valuation and Investment Value - The valuation of the North Exchange 50 index has significantly increased due to improved liquidity and the entry of institutional funds, with the valuation now at a higher level compared to the previous two years [8]. - Despite being higher than the main board, the valuation of the North Exchange 50 index is supported by growth potential, with the number of listed companies and market capitalization increasing over threefold [9]. - The index is characterized by a strong representation of emerging industries supported by national policies, such as electric equipment, computers, and biomedicine, which are expected to drive future performance [10].